Crossmark

Safety and efficacy of glecaprevir/pibrentasvir for the treatment of chronic hepatitis C in patients aged 65 years or older

Crossref DOI link: https://doi.org/10.1371/journal.pone.0208506

Published Online: 2019-01-02

Update policy: https://doi.org/10.1371/journal.pone.corrections_policy

Authors

Foster, Graham R. https://orcid.org/0000-0002-3704-386X
Asselah, Tarik

Kopecky-Bromberg, Sarah

Lei, Yang

Asatryan, Armen

Trinh, Roger

Zadeikis, Neddie

Mensa, Federico J. https://orcid.org/0000-0002-9421-1268
Funding

Funding for this research was provided by:

AbbVie
License Information

Version of Record valid from 2019-01-02